Application Nr Approved Date Route Status External Links
NDA021287 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Uroxatral Is Indicated For The Treatment Of Signs And Symptoms Of Benign Prostatic Hyperplasia. Uroxatral Is An Alpha Adrenergic Antagonist, Indicated For The Treatment Of Signs And Symptoms Of Benign Prostatic Hyperplasia. ( 1 ) Important Limitations Of Use: Uroxatral Is Not Indicated For Treatment Of Hypertension. ( 1.1 ) Uroxatral Is Not Indicated For Use In The Pediatric Population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations Of Use Uroxatral Is Not Indicated For The Treatment Of Hypertension. Uroxatral Is Not Indicated For Use In The Pediatric Population.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alfuzosin Hydrochloride ALFUZOSIN HYDROCHLORIDE ZINC1542392

Comments